siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy

BACKGROUND: Persistent infection with high-risk Human papillomaviruses (HPV), such as hr-HPV-16 and hr-HPV-18, lead to cervical cancer, the fourth most common cancer in the world. In the present study, we investigated the alteration of E6 oncogene expression by E6-specific short interfering RNA (siR...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiri Aghbash, Parisa, Hemmat, Nima, Baradaran, Behzad, Bannazadeh Baghi, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862546/
https://www.ncbi.nlm.nih.gov/pubmed/36681850
http://dx.doi.org/10.1186/s40001-023-01014-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862546/
https://www.ncbi.nlm.nih.gov/pubmed/36681850
http://dx.doi.org/10.1186/s40001-023-01014-9

Ejemplares similares